Steven Denbaars

CIK: 0001700533

Transaction Breakdown

Open Market Buys (P)2 (11.8%)

High conviction signal

Open Market Sales (S)10 (58.8%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (23.5%)

Compensation grants

Other (G, F, J, C, D, …)1 (5.9%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

ALMU

Aeluma, Inc.

Director

NONE

Palomino Laboratories Inc.

Director

SMTK

SmartKem, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (17 total)

ALMU
Aeluma, Inc.
Aug 27, 2026
Sale(S)
Direct
12.5K shares at avg. $13.82$173K
ALMU
Aeluma, Inc.
Aug 26, 2026
Sale(S)
Direct
12.5K shares at avg. $13.84$173K
ALMU
Aeluma, Inc.
May 20, 2026
Sale(S)
Direct
942 shares at avg. $21.30$20K
ALMU
Aeluma, Inc.
May 20, 2026
Sale(S)
Direct
11.6K shares at avg. $20.40$236K
ALMU
Aeluma, Inc.
May 19, 2026
Sale(S)
Direct
7.4K shares at avg. $19.56$145K
ALMU
Aeluma, Inc.
May 19, 2026
Sale(S)
Direct
5.1K shares at avg. $20.61$105K
No ticker
Palomino Laboratories Inc.
Apr 20, 2026
Purchase(P)
Direct
12.5K shares at avg. $4.00$50K
ALMU
Aeluma, Inc.
Feb 26, 2026
Sale(S)
Direct
12.5K shares at avg. $15.85$198K
ALMU
Aeluma, Inc.
Feb 25, 2026
Sale(S)
Direct
12.5K shares at avg. $17.58$220K
ALMU
Aeluma, Inc.
Dec 3, 2025
Award(A)
Direct
10.1K shares-
No ticker
Palomino Laboratories Inc.
Sep 29, 2025
Sale(S)
Warrants
Direct
125K shares at avg. $1.20-
No ticker
Palomino Laboratories Inc.
Sep 29, 2025
Other(J)
Direct
1.6M shares-
SMTK
SmartKem, Inc.
Sep 3, 2025
Award(A)
Stock Option (right to buy)
Direct
22.5K shares-
SMTK
SmartKem, Inc.
May 28, 2025
Award(A)
Stock Option (right to Buy)
Direct
23.9K shares-
ALMU
Aeluma, Inc.
Jan 10, 2025
Award(A)
Stock Option
Direct
84.7K shares at avg. $7.80-
ALMU
Aeluma, Inc.
Mar 1, 2024
Sale(S)
Stock Option
Direct
43.3K shares at avg. $2.99-
ALMU
Aeluma, Inc.
Dec 22, 2021
Purchase(P)
Direct
33.3K shares at avg. $3.00$100K

		Type	Shares	Price		Ownership
Aug 27, 2026	ALMU Aeluma, Inc.	Sale(S)	12,500	$13.82	$172,698	Direct
Aug 26, 2026	ALMU Aeluma, Inc.	Sale(S)	12,500	$13.84	$173,044	Direct
May 20, 2026	ALMU Aeluma, Inc.	Sale(S)	942	$21.30	$20,064	Direct
May 20, 2026	ALMU Aeluma, Inc.	Sale(S)	11,558	$20.40	$235,734	Direct
May 19, 2026	ALMU Aeluma, Inc.	Sale(S)	7,415	$19.56	$145,026	Direct
May 19, 2026	ALMU Aeluma, Inc.	Sale(S)	5,085	$20.61	$104,807	Direct
Apr 20, 2026	No ticker Palomino Laboratories Inc.	Purchase(P)	12,500	$4.00	$50,000	Direct
Feb 26, 2026	ALMU Aeluma, Inc.	Sale(S)	12,500	$15.85	$198,094	Direct
Feb 25, 2026	ALMU Aeluma, Inc.	Sale(S)	12,500	$17.58	$219,766	Direct
Dec 3, 2025	ALMU Aeluma, Inc.	Award(A)	10,121	-	$0	Direct
Sep 29, 2025	No ticker Palomino Laboratories Inc.	Sale(S) Warrants	125,000	$1.20	-	Direct
Sep 29, 2025	No ticker Palomino Laboratories Inc.	Other(J)	1,625,000	-	-	Direct
Sep 3, 2025	SMTK SmartKem, Inc.	Award(A) Stock Option (right to buy)	22,466	-	-	Direct
May 28, 2025	SMTK SmartKem, Inc.	Award(A) Stock Option (right to Buy)	23,915	-	-	Direct
Jan 10, 2025	ALMU Aeluma, Inc.	Award(A) Stock Option	84,663	$7.80	-	Direct
Mar 1, 2024	ALMU Aeluma, Inc.	Sale(S) Stock Option	43,279	$2.99	-	Direct
Dec 22, 2021	ALMU Aeluma, Inc.	Purchase(P)	33,333	$3.00	$99,999	Direct

1-17 of 17 transactions

About Denbaars Steven

Denbaars Steven (SEC CIK 0001700533) files insider reports with the SEC as Director of Aeluma, Inc. (ALMU), Director of Palomino Laboratories Inc. and Director of SmartKem, Inc. (SMTK).

Signal8 holds 11 ownership filings by Denbaars Steven (10 Form 4, 1 Form 5), filed between May 23, 2025 and Aug 28, 2026. Those filings report 17 transactions, from Dec 22, 2021 to Aug 27, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Denbaars Steven's filings is in GOLETA, CA.

Recent filings by Denbaars Steven

Aug 27, 2026: Open-market sale of ALMU shares (Form 4, code S).
Aug 26, 2026: Open-market sale of ALMU shares (Form 4, code S).
May 20, 2026: Open-market sales of ALMU shares (2 lines, Form 4, code S).
May 19, 2026: Open-market sales of ALMU shares (2 lines, Form 4, code S).
Apr 20, 2026: Open-market purchase of Palomino Laboratories Inc. shares (Form 4, code P).

Other insiders filing for Aeluma, Inc. (ALMU)

Klamkin Jonathan, Chief Executive Officer
Stewart Christopher P., Chief Financial Officer
Byron Michael, Director
ENSLEY CRAIG H, Director
Paglia John Kenneth, Director
Tompkins Mark N., 10% Owner

How to read Form 4 transaction codes